In fact, by shifting RAAS toward ANGII/AT1R, the level of inflammatory cytokines such as IL4, IL10 and IL6 are increased, which in turn activates T-cells in peripheral blood of COVID-19 patients. This evidence concerns the gene IL10 and COVID-19.